PRESCRIBING · PART D · 2024
Total Rx claims
451
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
18
Brand share
39.0%
Top prescribed drugs
Rifaximin70 claims
Furosemide49 claims
Spironolactone47 claims
Lactulose38 claims
Sofosbuvir/Velpatasvir29 claims
QUALITY · MIPS · 2024
Final MIPS score
84.1
Quality
69.2
Cost
73.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.38%
Group
CROSS-REFERENCE